Physician profile
Aruna Chakrala
NPI 1447366539
$1,761.93
in general payments reported to CMS, 2019-2025
13 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Adolescent Medicine (Internal Medicine) provider received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.12 · 2020: $23.61 · 2021: $359 · 2022: $647 · 2023: $440 · 2024: $102 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701 · Education: $20.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.92 |
| Education | $20.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $429.77 | 2022-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $420.05 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.81 | 2020-2024 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $239.69 | 2021-2024 | Farxiga |
| Arbor Pharmaceuticals, INC. | $112.19 | 2021 | |
| Abbott Laboratories | $79.02 | 2022-2023 | Freestyle Libre 3 |
| Amgen INC. | $77.66 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.92 | 2022 | |
| Exact Sciences Corporation | $34.17 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $30.42 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $28.29 | 2022 | |
| Astellas Pharma US INC | $14.47 | 2024 | Veozah |
| Genentech USA, INC. | $13.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aruna Chakrala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.